N G Industries Ltd (NGIND) — shareholding pattern, promoter holding, financials and share price
About N G Industries Ltd (NGIND)
N G Industries Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as NGIND and on the BSE under scrip code 530897. Its ISIN is INE825C01018.
Incorporated in 1994, N G Industries Ltd is in the business of providing healthcare services [1]
N G Industries Limited operates primarily in the healthcare sector, providing a range of medical services through divisions like N. G. Medicare & Calcutta Hope Infertility Clinic, N. G. Nursing Home, and N. G. Pharmacy.
Founded in 1994, the company pioneered private healthcare in Kolkata, eventually establishing a strong brand within the city and suburbs, particularly recognized in South Kolkata.
Listed peers in Healthcare Service Provider: Bandaram Pharma Packtech Ltd, Deccan Health Care Ltd, Sharma East India Hosp and Medical Research Ltd, Samsrita Labs Ltd, Tejnaksh Healthcare Ltd, Chennai Meenakshi Multispeciality Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹114.46 a share on 10 Jul 2026, N G Industries Ltd (NGIND) was valued at a price-to-earnings ratio of 22.17x against an industry P/E of 61.73x and a price-to-book of 1x on a book value of ₹114.96 per share as of Mar 2025. Solomo computes return on equity of 4.49% and return on capital employed of 5.46% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 22.17x
- Industry P/E
- 61.73x
- P/B
- 1x
- EPS (TTM)
- ₹5.16
- Book value / share
- ₹114.96
- ROE
- 4.49%
- ROCE
- 5.46%
- ROA
- 4.16%
- Debt / equity
- 0.05x
- Dividend yield
- 3.06%
- EBITDA margin
- 17.13%
- 52-week range
- ₹111 – ₹168.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, N G Industries Ltd (NGIND) reported revenue of ₹16.39 crore, net profit of ₹1.73 crore and earnings per share of ₹5.16. That compares with revenue of ₹16.55 crore and net profit of ₹7.74 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹4.36 crore and net profit ₹0.69 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 18.42 | 18.7 | 16.88 | 16.55 | 16.39 |
| Net profit (₹ cr) | 2.61 | 8.32 | 5.03 | 7.74 | 1.73 |
| EPS (₹) | 7.79 | 24.83 | 15.01 | 23.1 | 5.16 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -0.25% | -2.21% | -3.51% | -1.95% |
| Profit growth | 19.72% | 39.48% | 43.68% | 53.88% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.5% of N G Industries Ltd (NGIND) (unchanged from the previous quarter). Market capitalisation was ₹38 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: SATISH KANTILAL BORA 1.45%, KALPESH MANHERLAL CHOKHAWALA 1.04%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.5% | - | - | - | 25.5% |
| Mar 2026 | 74.5% | - | - | - | 25.5% |
| Dec 2025 | 74.5% | - | - | - | 25.5% |
| Sep 2025 | 74.5% | - | - | - | 25.5% |
| Jun 2025 | 74.5% | - | - | - | 25.5% |
| Mar 2025 | 74.5% | - | - | - | 25.5% |
| Dec 2024 | 74.5% | - | - | - | 25.5% |
| Sep 2024 | 74.5% | - | - | - | 25.5% |